Beck Mack & Oliver LLC raised its stake in Waters Co. (NYSE:WAT) by 9.1% in the 4th quarter, HoldingsChannel reports. The fund owned 402,713 shares of the medical instruments supplier’s stock after buying an additional 33,730 shares during the quarter. Waters accounts for about 3.0% of Beck Mack & Oliver LLC’s holdings, making the stock its 9th biggest holding. Beck Mack & Oliver LLC’s holdings in Waters were worth $75,972,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of WAT. Schroder Investment Management Group increased its position in Waters by 64.8% in the 2nd quarter. Schroder Investment Management Group now owns 208,983 shares of the medical instruments supplier’s stock valued at $40,501,000 after acquiring an additional 82,175 shares in the last quarter. Bank of New York Mellon Corp increased its position in Waters by 156.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,358,976 shares of the medical instruments supplier’s stock valued at $843,852,000 after acquiring an additional 2,657,055 shares in the last quarter. State of Alaska Department of Revenue increased its position in Waters by 6.6% in the 3rd quarter. State of Alaska Department of Revenue now owns 15,715 shares of the medical instruments supplier’s stock valued at $3,057,000 after acquiring an additional 969 shares in the last quarter. Personal Capital Advisors Corp increased its position in Waters by 68.1% in the 3rd quarter. Personal Capital Advisors Corp now owns 3,198 shares of the medical instruments supplier’s stock valued at $623,000 after acquiring an additional 1,295 shares in the last quarter. Finally, DNB Asset Management AS increased its position in Waters by 11.1% in the 3rd quarter. DNB Asset Management AS now owns 13,309 shares of the medical instruments supplier’s stock valued at $2,591,000 after acquiring an additional 1,326 shares in the last quarter. Hedge funds and other institutional investors own 92.30% of the company’s stock.

In related news, SVP Terrence P. Kelly sold 21,028 shares of Waters stock in a transaction that occurred on Tuesday, December 11th. The shares were sold at an average price of $190.07, for a total transaction of $3,996,791.96. Following the transaction, the senior vice president now owns 9,541 shares of the company’s stock, valued at approximately $1,813,457.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 8,000 shares of Waters stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $199.67, for a total transaction of $1,597,360.00. Following the transaction, the director now directly owns 18,911 shares in the company, valued at approximately $3,775,959.37. The disclosure for this sale can be found here. Insiders have sold a total of 97,249 shares of company stock worth $20,981,857 in the last three months. 0.98% of the stock is owned by insiders.

Several equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $256.00 price objective for the company in a research report on Wednesday, January 30th. BTIG Research raised their price objective on shares of Waters to $260.00 and gave the company a “buy” rating in a research report on Thursday, January 24th. Robert W. Baird cut shares of Waters from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $191.00 to $211.00 in a research report on Thursday, January 24th. Barclays restated a “hold” rating and issued a $200.00 price objective on shares of Waters in a research report on Friday, January 25th. Finally, TheStreet raised shares of Waters from a “c+” rating to a “b” rating in a research note on Thursday, January 17th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $208.99.

Shares of NYSE WAT opened at $232.61 on Thursday. The stock has a market capitalization of $17.44 billion, a PE ratio of 28.06, a price-to-earnings-growth ratio of 2.28 and a beta of 1.17. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.01 and a current ratio of 2.26. Waters Co. has a 1 year low of $167.93 and a 1 year high of $233.48.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.64 by $0.23. The company had revenue of $715.00 million for the quarter, compared to analyst estimates of $702.74 million. Waters had a net margin of 24.54% and a return on equity of 34.18%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.51 EPS. Analysts expect that Waters Co. will post 9.35 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Beck Mack & Oliver LLC Purchases 33,730 Shares of Waters Co. (WAT)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.watchlistnews.com/beck-mack-oliver-llc-purchases-33730-shares-of-waters-co-wat/2802007.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: How to Calculate Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.